<DOC>
	<DOCNO>NCT00405535</DOCNO>
	<brief_summary>The purpose study determine whether individual obsessive compulsive disorder take preparation amino acid glycine addition current treatment , may experience improvement symptom .</brief_summary>
	<brief_title>Adjunctive Glycine Obsessive Compulsive Disorder</brief_title>
	<detailed_description>Individuals obsessive compulsive disorder ( OCD ) often find inadequate relief , even best currently available treatment . Some evidence suggest neurotransmitter glutamate may useful target new treatment OCD . The amino acid glycine , give orally adequate dosage , specific effect one particular glutamate receptor molecule brain , might helpful OC symptom . This randomized , double-blind protocol study participant suffer OCD take either glycine preparation placebo 12 week . Clinical measure ( e.g. , Y-BOCS , NIMH-OC ) record visit determine whether take glycine experience clinical benefit .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Glycine</mesh_term>
	<criteria>Diagnosis OCD present least 1 year Male female , age 18 65 Stable medication regimen 12 week prior study entry least moderately severe OC symptom Active substance use disorder within last 6 month Comorbid schizophrenia , schizoaffective disorder , bipolar disorder , tic disorder , Tourette Disorder , schizotypal personality disorder Hoarding principal OCD symptom Insulindependent diabetes mellitus Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>OCD</keyword>
	<keyword>Obsessive Compulsive Disorder</keyword>
	<keyword>Glycine</keyword>
</DOC>